Oncoinvent ASA (0RU5.L) LSE
Currency In NOK
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 60.72M |
| Enterprise Value | -113.33M |
| P/E Ratio | -1.61 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 30.88 |
| Price/Book Ratio | 7.47 |
| Enterprise/Revenue | 25.51 |
| Enterprise/EBITDA | -3.32 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -8.77 |
| Operating Margin | -8.12 |
AD
Management Effectiveness
| Return On Assets | -1.33 |
| Return On Equity | -1.51 |
Income Statement
| Revenue | 23.04M |
| Revenue/Share | 4.36 |
| Gross Profit | -64.31M |
| EBITDA | -130.48M |
| Net Income | -155.07M |
| Diluted EPS | -125.13 |
Balance Sheet
| Total Cash | 177.6M |
| Total Cash/Share | 23.84 |
| Total Debt | 3.55M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 2.43 |
| Book Value Per Share | 18.01 |
Price History
| 52-Week Change | 86.71 |
| 52-Week High | 135 |
| 52-Week Low | 0.08 |
| Moving Average 50 Days | 0.26 |
| Moving Average 200 Days | 0.51 |
Statistics
| Average Volume | 238,757 |
| Shares Outstanding | 39.09M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | May 30, 2024 |
AD
